Government Purchasing of Medicines for the Public Health: The Cases of HCV and PrEP
To promote patient access to expensive essential medicines, there has been growing interest in government purchasing of drugs that could then be made widely available. We will examine two case studies of this approach—direct-acting antivirals for hepatitis C virus and pre-exposure prophylaxis for HIV prevention—to understand how these programs work and how they navigate patents, drug regulations, and public health law.
Speakers
Boston University Questrom School of Business
Rena ContiDean’s Research Scholar, Associate Professor, Markets, Public Policy, and Law,Johns Hopkins Bloomberg School of Public Health
Joshua SharfsteinVice Dean for Public Health Practice and Community Engagement and Professor of the PracticeJohns Hopkins Bloomberg School of Public Health
Amy KillelaOwner, Killela Consulting; Senior Associate in the Health Policy and Management Program
Contact
Emily Rock
Host Organization
- Solomon Center for Health Law and Policy
Admission
Free
Tag
Other
Food
Lunch